Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activation of helper T cells refers to the process by which CD4+ T lymphocytes recognize antigen-bound MHC class II on antigen-presenting cells, receive co-stimulatory signals (primarily through CD28 and other receptors), and undergo clonal expansion and differentiation into various effector subtypes (Th1, Th2, Th17, etc.). This activation orchestrates adaptive immune responses, driving antibody production (by B-cell help), cell-mediated immunity, cytokine secretion, and immune memory formation. Therapeutic targeting of this process typically involves inhibition or modulation of molecular participants like the T cell receptor (TCR), CD3, CD28, CD40L, or related cytokine and signal transduction pathways. Overactivation or misregulation can lead to allergy, autoimmunity, and inflammatory disease, while deficient activation can result in immunodeficiency and poor infection or tumor control.
Inhibition of co-stimulatory signals (blocking CD28/B7 interaction); Inhibition of T-cell receptor signaling; Blocking cytokine signaling (e.g. IL-2, IL-4, IFN-γ); Inhibition of CD40L/CD40 interaction; Suppression of transcription factors (e.g. NFAT, STATs)
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helper T cell activation (activation of CD4+ T cells) (None).